ClinicalTrials.Veeva

Menu

Exercises in the Post-operative Rehabilitation of THA

F

Federal University of Health Science of Porto Alegre

Status

Unknown

Conditions

Hip Osteoarthritis

Treatments

Other: Rehabilitation exercises
Other: Postoperative guidance

Study type

Interventional

Funder types

Other

Identifiers

NCT03208829
THA Rehabilitation

Details and patient eligibility

About

Subjects submitted to unilateral THA will be randomized into two rehabilitation groups. One group will receive a booklet with guidelines for postoperative care, while the other group will participate in face-to-face sessions with exercises with emphasis on muscle strengthening.

Full description

Individuals with osteoarthritis (OA) of the hip submitted to total hip arthroplasty (THA) may present alterations in their functional capacity, and associated, among other aspects, the reduction in muscle strength. Our overall objective is to compare the effects of an exercise program based on training of muscular strength to orientations and functional home exercises in patients submitted to THA, as well as to compare the outcomes of both groups with those of healthy individuals. Individuals with THA will be randomly assigned to two groups. One group will receive face-to-face treatment (G1) and the other will receive postoperative guidance (G2). A blinded appraiser regarding the allocation will apply the evaluation tools at the moments: preintervention, after completing 7 days and after 10 weeks of the end of the treatment. The research will present as clinical outcomes: the muscular strength, through the values of torque peaks obtained in dynamometry; the functional capacity through the results of the Timed Up and Go test and the Harris Hip Score questionnaire; the range of joint motion measured with and flexometer; the pain through the results of the numerical scale of pain; and kinesiophobia, through the scores obtained in the Tampa Scale.

Enrollment

84 estimated patients

Sex

All

Ages

50+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Referred by orthopedic doctors of the city of Porto Alegre, Rio Grande do Sul, Brazil;
  • Between 30-60 days of unilateral total hip arthroplasty (cemented and hybrid prostheses) postoperative phase;
  • Read and consent to the Free and Informed Consent Form and understood the guidelines necessary to carry out the evaluations proposed in this research.

Exclusion criteria

  • Performing a surgical procedure, in the last six months, in other articular joints in the lower limbs;
  • previous surgical procedures in the coxofemoral joint;
  • surgical procedures and osteoarticular diseases in the lumbar spine;
  • osteoarticular diseases in lower limb joints;
  • muscle injuries in lower limbs;
  • presence of signs or symptoms of osteoarthritis in the contralateral hip;
  • postoperative complications such as prosthesis dislocation, deep venous thrombosis, periarticular fractures and neural lesions;
  • intra-articular injection of corticosteroids in the lower limbs during the last six months;
  • cardiovascular diseases with presence of disability, such as severe dyspnea and uncontrolled arterial hypertension;
  • presence of neurological diseases.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

84 participants in 2 patient groups

Group 1
Experimental group
Description:
Rehabilitation Exercises Group 1 will be submitted to an exercise protocol based on muscle strength training, with duration of 6 weeks and frequency of two weekly sessions, lasting 45 minutes.
Treatment:
Other: Rehabilitation exercises
Group 2
Active Comparator group
Description:
Postoperative guidance Group 2 will receive an orientation booklet and weekly links from researchers to address possible questions.
Treatment:
Other: Postoperative guidance

Trial contacts and locations

1

Loading...

Central trial contact

Marcelo F Silva, PhD; Bruna M Lopes, PhD Student

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems